Visceral Adiposity Mitigation is the clinical strategy focused on reducing the amount of fat stored specifically within the abdominal cavity, surrounding vital internal organs. This type of fat is highly metabolically active and secretes pro-inflammatory adipokines that drive insulin resistance, cardiovascular risk, and hormonal dysregulation. Mitigation protocols involve a Systems-Level Intervention to decrease this harmful fat depot and improve overall metabolic and endocrine health.
Origin
This term is rooted in metabolic medicine and cardiology, recognizing the distinct pathological risk posed by visceral fat compared to subcutaneous fat. The clinical imperative is ‘Mitigation’ due to the strong correlation between visceral adiposity and the cluster of symptoms known as metabolic syndrome. It represents a targeted health goal in longevity and chronic disease prevention.
Mechanism
Mitigation is achieved by correcting the hormonal and metabolic drivers of visceral fat accumulation. High cortisol levels and chronic hyperinsulinemia are key culprits; therefore, interventions
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.